Zofran

Company: GlaxoSmithKline
Approval Status: Approved January 1999
Treatment for: Oncology
Areas: Cancer & Oncology
Possible similar drugs: Zofran

| General Information |

General Information

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.

< back to top

Zofran Drug Information

The Zofran drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.